Novartis recalls Foradil Aerolizer it makes for Merck; Elder to make products being bought by Torrent;

> American Enterprise Institute researcher Roger Bate is questioning why the United States Pharmacopeia and the Ghana Food and Drug Authority have redacted the names of mostly Indian and Chinese manufacturers initially named in a report on substandard drugs found in the country. Blog Post

> Novartis ($NVS) is recalling 109,155 Foradil Aerolizer containing capsules of formoterol fumarate inhalation powder for treating asthma that is makes for Merck ($MRK) because they were out of specification for particles size. Report

> The FDA has sent a warning letter to Randolph, NJ-based compounding pharmacy Pharmacy Creations. Warning Letter

> Elder will continue to manufacture products for three years for Torrent, which is buying its branded drug business for Rs 2,000 crore. Story

> Microtest Laboratories, which specializes in biopharma testing services and contract manufacturing, has put out a new whitepaper on the benefits of stability testing. More

> A new reports says that contract manufacturing capacity for production of cytotoxic injectable drugs will be tight over the next 5 years. Access

And Finally... Freightwatch International reminds the pharma industry that previous losses over the July 4 holiday in the U.S. have included a full truckload theft of scheduled drugs in Troy, IL, and the $80,000 theft from a trailer of over-the-counter medication in Cedar Rapids, IA.

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.